Cargando…
COVID y rellenos faciales ¿realmente debemos preocuparnos?
SARS-CoV-2 has caused millions of infections and deaths worldwide and case numbers continue to rise. Besides the effect of the virus on key organs — leading to respiratory illness, anosmia, diarrhea, and fever and other complications — delayed inflammatory reactions to hyaluronic acid dermal fillers...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AEDV. Published by Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159960/ https://www.ncbi.nlm.nih.gov/pubmed/35659611 http://dx.doi.org/10.1016/j.ad.2022.05.019 |
_version_ | 1784719171731324928 |
---|---|
author | López Pérez, V. |
author_facet | López Pérez, V. |
author_sort | López Pérez, V. |
collection | PubMed |
description | SARS-CoV-2 has caused millions of infections and deaths worldwide and case numbers continue to rise. Besides the effect of the virus on key organs — leading to respiratory illness, anosmia, diarrhea, and fever and other complications — delayed inflammatory reactions to hyaluronic acid dermal fillers, mainly in the face, have also been reported to occur after confirmed SARS-CoV-2 infections and in vaccinated individuals. While delayed inflammatory reactions tend to be self-limiting, they should be diagnosed and treated with corticosteroids, hyaluronidase, and/or antibiotics when necessary. The inflammation is generally not severe, yet these complications are classified as serious adverse events by the US Food and Drug Administration. They appear to be delayed type IV hypersensitivity reactions triggered by the immune system in the presence of SARS-CoV-2 or other viruses, such as those causing influenza, although the underlying mechanisms have not been fully elucidated. Because the longevity of dermal fillers is increasing, while the pandemic continues to evolve and new vaccines are under development, the long-term effects on hyaluronic acid fillers and other bioimplant materials should be studied. Physicians must also be encouraged to report these reactions, however mild, to ensure accurate records. |
format | Online Article Text |
id | pubmed-9159960 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AEDV. Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91599602022-06-02 COVID y rellenos faciales ¿realmente debemos preocuparnos? López Pérez, V. Actas Dermosifiliogr Revisión SARS-CoV-2 has caused millions of infections and deaths worldwide and case numbers continue to rise. Besides the effect of the virus on key organs — leading to respiratory illness, anosmia, diarrhea, and fever and other complications — delayed inflammatory reactions to hyaluronic acid dermal fillers, mainly in the face, have also been reported to occur after confirmed SARS-CoV-2 infections and in vaccinated individuals. While delayed inflammatory reactions tend to be self-limiting, they should be diagnosed and treated with corticosteroids, hyaluronidase, and/or antibiotics when necessary. The inflammation is generally not severe, yet these complications are classified as serious adverse events by the US Food and Drug Administration. They appear to be delayed type IV hypersensitivity reactions triggered by the immune system in the presence of SARS-CoV-2 or other viruses, such as those causing influenza, although the underlying mechanisms have not been fully elucidated. Because the longevity of dermal fillers is increasing, while the pandemic continues to evolve and new vaccines are under development, the long-term effects on hyaluronic acid fillers and other bioimplant materials should be studied. Physicians must also be encouraged to report these reactions, however mild, to ensure accurate records. AEDV. Published by Elsevier España, S.L.U. 2022-10 2022-06-02 /pmc/articles/PMC9159960/ /pubmed/35659611 http://dx.doi.org/10.1016/j.ad.2022.05.019 Text en © 2022 AEDV. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Revisión López Pérez, V. COVID y rellenos faciales ¿realmente debemos preocuparnos? |
title | COVID y rellenos faciales ¿realmente debemos preocuparnos? |
title_full | COVID y rellenos faciales ¿realmente debemos preocuparnos? |
title_fullStr | COVID y rellenos faciales ¿realmente debemos preocuparnos? |
title_full_unstemmed | COVID y rellenos faciales ¿realmente debemos preocuparnos? |
title_short | COVID y rellenos faciales ¿realmente debemos preocuparnos? |
title_sort | covid y rellenos faciales ¿realmente debemos preocuparnos? |
topic | Revisión |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159960/ https://www.ncbi.nlm.nih.gov/pubmed/35659611 http://dx.doi.org/10.1016/j.ad.2022.05.019 |
work_keys_str_mv | AT lopezperezv covidyrellenosfacialesrealmentedebemospreocuparnos |